Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Phase IIa Clinical Trial Of Cyclosporine For The Treatment Of COVID-19(+) Non-ICU Hospital Inpatients

NCT04492891 is registered in ClinicalTrials.gov with Bryan Burt, MD as lead sponsor.

NCT NCT04492891
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04492891 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Phase IIa Clinical Trial Of Cyclosporine For The Treatment Of COVID-19(+) Non-ICU Hospital Inpatients
Lead sponsor
Bryan Burt, MD
Phase
Phase 2
Overall status
Completed
Start date
November 23, 2020
Completion date
December 10, 2021
Enrollment
47 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sars (disease)